161 related articles for article (PubMed ID: 28438487)
1. ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Baur B; Bozdag S
Genomics; 2017 Jul; 109(3-4):233-240. PubMed ID: 28438487
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
3. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
4. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
5. Identifying in-trans process associated genes in breast cancer by integrated analysis of copy number and expression data.
Aure MR; Steinfeld I; Baumbusch LO; Liestøl K; Lipson D; Nyberg S; Naume B; Sahlberg KK; Kristensen VN; Børresen-Dale AL; Lingjærde OC; Yakhini Z
PLoS One; 2013; 8(1):e53014. PubMed ID: 23382830
[TBL] [Abstract][Full Text] [Related]
6. Interaction-Based Feature Selection for Uncovering Cancer Driver Genes Through Copy Number-Driven Expression Level.
Park H; Niida A; Imoto S; Miyano S
J Comput Biol; 2017 Feb; 24(2):138-152. PubMed ID: 27759426
[TBL] [Abstract][Full Text] [Related]
7. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method.
Amgalan B; Lee H
Bioinformatics; 2015 Aug; 31(15):2452-60. PubMed ID: 25819079
[TBL] [Abstract][Full Text] [Related]
8. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
[TBL] [Abstract][Full Text] [Related]
9. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
10. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
11. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
12. Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer.
Zhang L; Yuan Y; Lu KH; Zhang L
BMC Bioinformatics; 2016 May; 17(1):222. PubMed ID: 27230211
[TBL] [Abstract][Full Text] [Related]
13. Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.
Wang G; Anastassiou D
Sci Rep; 2020 Oct; 10(1):17199. PubMed ID: 33057153
[TBL] [Abstract][Full Text] [Related]
14. Identifying candidate drivers of drug response in heterogeneous cancer by mining high throughput genomics data.
Nabavi S
BMC Genomics; 2016 Aug; 17(1):638. PubMed ID: 27526849
[TBL] [Abstract][Full Text] [Related]
15. Inferring causal genomic alterations in breast cancer using gene expression data.
Tran LM; Zhang B; Zhang Z; Zhang C; Xie T; Lamb JR; Dai H; Schadt EE; Zhu J
BMC Syst Biol; 2011 Aug; 5():121. PubMed ID: 21806811
[TBL] [Abstract][Full Text] [Related]
16. Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach.
Srihari S; Kalimutho M; Lal S; Singla J; Patel D; Simpson PT; Khanna KK; Ragan MA
Mol Biosyst; 2016 Mar; 12(3):963-72. PubMed ID: 26805938
[TBL] [Abstract][Full Text] [Related]
17. Engineering targeted chromosomal amplifications in human breast epithelial cells.
Springer S; Yi KH; Park J; Rajpurohit A; Price AJ; Lauring J
Breast Cancer Res Treat; 2015 Jul; 152(2):313-21. PubMed ID: 26099605
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors.
Ohshima K; Hatakeyama K; Nagashima T; Watanabe Y; Kanto K; Doi Y; Ide T; Shimoda Y; Tanabe T; Ohnami S; Ohnami S; Serizawa M; Maruyama K; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
Sci Rep; 2017 Apr; 7(1):641. PubMed ID: 28377632
[TBL] [Abstract][Full Text] [Related]
19. A sparse regulatory network of copy-number driven gene expression reveals putative breast cancer oncogenes.
Yuan Y; Curtis C; Caldas C; Markowetz F
IEEE/ACM Trans Comput Biol Bioinform; 2012; 9(4):947-54. PubMed ID: 21788678
[TBL] [Abstract][Full Text] [Related]
20. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
